Early protocol biopsies in pediatric renal transplantation: interest for the adaptation of immunosuppression.
Bruel, Alexandra; Allain-Launay, Emma; Humbert, Julie; Ryckewaert, Amélie; Champion, Gérard; Moreau, Anne; Renaudin, Karine; Karam, Georges; Roussey-Kesler, Gwenaelle.
; 18(2): 142-9, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24341571
Outcomes of two-drug maintenance immunosuppression for pediatric renal transplantation: 10-yr follow-up in a single center.
Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation.
No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experience.
Mycophenolate mofetil administered every 8 hours in combination with tacrolimus is efficacious in the prophylaxis of acute graft versus host disease in childhood, adolescent, and young adult allogeneic stem cell transplantation recipients.
Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients.
Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial.
Discontinuation of steroids in ABO-incompatible renal transplantation.
Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation.
Pharmacokinetics of Mycophenolic Acid and Dose Optimization in Children After Intestinal Transplantation.
Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.